MIMS UKfremanezumabmigraineMDDmajor depressive disorder
…ther CGRP pathway mAbs: 52%) and drug/administration costs from MIMS UK and the National Schedule of National Health Service costs, 202…
5,089articles mentioning funders
9,137funder mentions
3,238distinct funders extracted
0%of mentions human-reviewed
All extracted funders
Showing 961–1,020 of 3,238, ordered by supporting articles. Choose a funder to see its evidence.
British Standard Institution1Bromley Research Ethics Committee1Bruyère Health Research Ethics Board1Bundesinstitut fuer Arzneimittel und Medizinprodukte1Bundesinstitut für Arzneimittel und Medizinprodukte1Bureau of Alcohol, Tobacco, Firearms and Explosives1Bureau of Alcohol, Tobacco, and Firearms1Burroughs Wellcome Physician-Scientist Award1Butterwick Hospice1C17101C3/20/0401CA232561-01A11CASEM1CCM1CCP Ouest 21CDRF1CEDI-FMUSP1CEN1CER-VD1CER-VD 2025-005031CF Foundation1CF0s1CGMF1CHC1CHIPER Health Research Ethics Board1CIRP1CIUSSS du Nord-de-l’Île-de-Montréal Research Ethics Board1CIV-23-02-0424361CJG Fund1CNCS - UEFISCDI1CONEP1CONMEBOL1CORE1CPP Est 11CPP Est II-2024-A02224-431CPP Nord-Ouest I1CPP Ouest III1CPP Sud-Est V1CQHHS1CRB0111-251CRIS Foundation Out-Back Fellowship Programme1CROs1CSL1CTFPHC1CTRI1CVS Health1California Managed Care Plans1Cambridgeshire and Peterborough NHS Foundation Trust1Camden Primary Care Network1Canada1Canadian Agency for Drugs1Canadian Agency for Drugs and Technologies in Health1Canadian Cancer Society1Canadian Council1Canadian Red Cross1Canadian government1Cancer Alliance1Cancer Cures 4 Kids1Carelon Research/Elevance Health1Carers UK1
Articles mentioning funders
5,089 articles · page 303 of 425NHS TaysideIdiopathic Intracranial Hypertension (IIH)Idiopathic intracranial hypertension
…standardised referral and follow-up pathway for IIH patients in NHS Tayside.Methods Patients who had a lumbar puncture between May 2023 and…
Early Access to Medicine SchemeefartigimodefgartigimodNHNNResultsIV efartigmodefgartigmodSC efartigmodIV efargartigmodNHNNefgartigmodMethods+1 more
…ralised MG (gMG). Efartigimod was available in the UK under the Early Access to Medicine Scheme from May 2022 to Dec 2024 with over 100 patients treated to dat…
Eli Lilly and CompanyremternetugADAlzheimer’s disease
…n (>50% very low/no tau assessed by tau PET). TR3, sponsored by Eli Lilly and Company, is being conducted at multiple sites globally. Enrollment open…
NCT05119569FenebrutinibRMSCOVID-19UTIpharyngitisMSOLE
…on’s tyrosine kinase inhibitor. In the Phase II FENopta study ( NCT05119569), participants received Fenebrutinib 200mg orally BID or placeb…
Integrated Care Boardsmyasthenia gravisMG
…is has a number of inefficiencies and delegated budgets through Integrated Care Boards (ICB’s) budgets provide us an opportunities to address these ga…
Western Health and Social Care Trust
… in a single health trust in Northern Ireland over 5 years (the Western Health and Social Care Trust). A simultaneous retrospective audit of incidental CNS oncology…
NICE-PerformaNeurology DepartmentCNS malignancyBasildon Hospitalbenign tumours
…ost 60% of referrals were found to be non-compliant to standard NICE-Performa/guidelines for Brain and CNS Malignancy Pathway. Amongst these,…
NCT04998812ocrelizumabMS
…MINORE ( NCT04998812) is a prospective Phase IV, open-label study measuring ocrelizu…
NCT04998851ocrelizumabmultiple sclerosisWwMS
…SOPRANINO ( NCT04998851) is the first prospective study measuring both pharmacodynamic …
NICEcannabidiolCenobamateLennox-Gastaut syndromeketogenic dietAdjuvant cenobamate
…te of whom fourteen were still on cannabidiol as they fulfilled NICE criteria for continuing prescribing. Of these, 8 had a Vagus Ne…
National Health ServicePwPDParkinson’s disease
…Improving equitable access to studies is a key objective of the National Health Service. Research registries can improve recruitment.Aim To build a sus…